A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease

被引：10
|
作者：
Faridar, Alireza [1 ]
Eid, Abdulmunaim M. [1 ]
Thome, Aaron D. [1 ]
Zhao, Weihua [1 ]
Beers, David R. [1 ]
Pascual, Maria B. [1 ]
Nakawah, Mohammad O. [1 ]
Roman, Gustavo C. [1 ]
Davis, Charles S. [2 ]
Grundman, Michael [3 ,4 ]
Masdeu, Joseph C. [1 ]
Appel, Stanley H. [1 ]
机构：
[1] Houston Methodist Res Inst, Stanley H Appel Dept Neurol, 6565 Fannin St,Suite P3-201, Houston, TX 77030 USA
[2] CSD Biostat Inc, Oro Valley, AZ USA
[3] Global R&D Partners LLC, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA USA
来源：
TRANSLATIONAL NEURODEGENERATION | 2023年 / 12卷 / 01期
关键词：
D O I：
10.1186/s40035-023-00387-5
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Trial registrationClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The effect of prucalopride on gastric emptying in Parkinson's disease patients, a pilot randomized, open-label study
    Pinyopornpanish, Kanokwan
    Kijdamrongtham, Phuripong
    Soontornpun, Atiwat
    Teeyasoontranon, Waralee
    Angkurawaranon, Chaisiri
    Thongsawat, Satawat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 113 - 113
  • [42] Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study
    Khlebtovsky, Alexander
    Steiner, Israel
    Treves, Therese
    Djaldetti, Ruth
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, : 586 - 590
  • [43] A phase 1/2, open-label study of SPK-10002 gene therapy in patients with Fabry disease
    James, Rebecca
    Jaeger, Savina
    Palanichamy, Arumugam
    Williamson, Zachary
    Tiffany, Courtney
    Jain, Meena
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [44] Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial
    Groen, Kaz
    Stege, Claudia A. M.
    Nasserinejad, Kazem
    de Heer, Koen
    van Kampen, Roel J. W.
    Leys, Rineke B. L.
    Thielen, Noortje
    Westerman, Matthijs
    Wu, Ka-Lung
    Ludwig, Inge
    Issa, Djamila E.
    Velders, Gerjo A.
    Vekemans, Marie-Christiane
    Timmers, Gert-Jan
    de Boer, Fransien
    Tick, Lidwine W.
    Verbrugge, Annelies
    Buitenhuis, Danny
    Cunha, Sonia M.
    van der Spek, Ellen
    de Waal, Esther G. M.
    Sohne, Maaike
    Sonneveld, Pieter
    Nijhof, Inger S.
    Klein, Saskia K.
    van der Donk, Niels W. C. J.
    Levin, Mark-David
    Ypma, Paula F.
    Zweegman, Sonja
    ECLINICALMEDICINE, 2023, 63
  • [45] A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma
    Zonder, Jeffrey A.
    Mohrbacher, Ann F.
    Singhal, Seema
    van Rhee, Frits
    Bensinger, William I.
    Ding, Han
    Fry, John
    Afar, Daniel E. H.
    Singhal, Anil K.
    BLOOD, 2012, 120 (03) : 552 - 559
  • [46] A Phase 1, Open-Label, Single-Dose Pharmacokinetic Study of Lasmiditan in Paediatric Patients with Migraine
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen
    Wilbraham, Darren
    NEUROLOGY, 2021, 96 (15)
  • [47] Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study
    Salloway, Stephen
    Marshall, Gad A.
    Lu, Ming
    Brashear, H. Robert
    CURRENT ALZHEIMER RESEARCH, 2018, 15 (13) : 1231 - 1243
  • [48] A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PAEDIATRIC PATIENTS WITH MIGRAINE
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen B.
    Wilbraham, Darren
    CEPHALALGIA, 2020, 40 : 41 - 42
  • [49] An open-label study of Escitalopram (Lexapro®) for the treatment of 'Depression of Alzheimer's disease' (dAD)
    Rao, V
    Spiro, JR
    Rosenberg, PB
    Lee, HB
    Rosenblatt, A
    Lyketsos, CG
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (03) : 273 - 274
  • [50] Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study
    Dakhale, Ganesh N.
    Sharma, Vikas Sohanlal
    Thakre, Manish N.
    Kalikar, Mrunalini
    INDIAN JOURNAL OF PHARMACOLOGY, 2019, 51 (04) : 255 - 262
12345